ArticleJournal of hematology & oncology2019
The IAP antagonist birinapant potentiates bortezomib anti-myeloma activity in vitro and in vivo.
Liang Zhou et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
19 papers cite it
this papercites it